Positron emission tomography (PET) is a noninvasive imaging technique that provides a
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …

Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …

Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

Metastatic prostate cancer may respond initially to hormone suppression, with involution of
tumor sites, but ultimate tumor progression is inevitable. Our aim was to detect the proportion …

We evaluated whether tracer FDG uptake, quantified as an SUV by PET in ovarian epithelial
tumors, correlates with clinical stage, tumor grade, cell proliferation and glucose metabolism …

The aim of our study was to describe 18F-fluorodeoxyglucose (FDG) positron emission
tomography (PET) findings of a localized form of bronchioloalveolar carcinoma and to …

Simple Summary Breast cancer is one of the most commonly diagnosed malignant tumors,
possessing high incidence and mortality rates that threaten women's health. Thus, early and …

Objectives L-[3-18 F]-α–methyltyrosine (18 F-FMT) is an amino-acid tracer for positron
emission tomography (PET) and is used for tumor detection because malignant tumor cells …

Amino acids are required nutrients for proliferating tumor cells, and amino acid transport is
upregulated in many tumor types. Studies of radiolabeled amino acids in animals and …

PURPOSE:(a) To implement a fully automatic method to integrate 11C-methionine positron
emission tomography (MET-PET) data into stereotactic radiation treatment planning using …